Northern Trust
RVMD icon

Northern Trust’s Revolution Medicines RVMD Stock Holding History

Northern Trust’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$209M Buy
1,117,110
+162,854
+17% +$23.8M 0.02% 498
2026
Q1 		$92.8M Buy
954,256
+103,933
+12% +$10.5M 0.01% 779
2025
Q4 		$67.7M Sell
850,323
-9,225
-1% -$605K 0.01% 935
2025
Q3 		$40.1M Buy
859,548
+2,925
+0.3% +$115K 0.01% 1269
2025
Q2 		$31.5M Sell
856,623
-678,134
-44% -$26.1M ﹤0.01% 1380
2025
Q1 		$54.3M Sell
1,534,757
-5,321
-0.3% -$216K 0.01% 1037
2024
Q4 		$67.4M Buy
1,540,078
+228,790
+17% +$11.5M 0.01% 942
2024
Q3 		$59.5M Buy
1,311,288
+131,272
+11% +$5.72M 0.01% 916
2024
Q2 		$45.8M Sell
1,180,016
-34,255
-3% -$1.28M 0.01% 1051
2024
Q1 		$39.1M Sell
1,214,271
-56,524
-4% -$1.68M 0.01% 1147
2023
Q4 		$36.4M Buy
1,270,795
+337,670
+36% +$8.11M 0.01% 1239
2023
Q3 		$25.8M Buy
933,125
+15,432
+2% +$458K 0.01% 1376
2023
Q2 		$24.5M Buy
917,693
+132,136
+17% +$3.24M ﹤0.01% 1451
2023
Q1 		$17M Buy
785,557
+109,885
+16% +$2.71M ﹤0.01% 1656
2022
Q4 		$16.1M Buy
675,672
+18,712
+3% +$398K ﹤0.01% 1683
2022
Q3 		$13M Buy
656,960
+17,796
+3% +$391K ﹤0.01% 1801
2022
Q2 		$12.5M Buy
639,164
+9,315
+1% +$181K ﹤0.01% 1862
2022
Q1 		$16.1M Buy
629,849
+68,794
+12% +$1.5M ﹤0.01% 1829
2021
Q4 		$14.1M Buy
561,055
+1,387
+0.2% +$39.1K ﹤0.01% 2004
2021
Q3 		$15.4M Sell
559,668
-6,247
-1% -$182K ﹤0.01% 1975
2021
Q2 		$18M Buy
565,915
+94,062
+20% +$3.28M ﹤0.01% 1958
2021
Q1 		$21.6M Buy
471,853
+27,583
+6% +$1.24M ﹤0.01% 1757
2020
Q4 		$17.6M Sell
444,270
-7,498
-2% -$296K ﹤0.01% 1879
2020
Q3 		$15.7M Buy
451,768
+255,285
+130% +$7.07M ﹤0.01% 1804
2020
Q2 		$6.2M Buy
196,483
+46,091
+31% +$1.45M ﹤0.01% 2383
2020
Q1 		$3.3M Buy
+150,392
New +$4.16M ﹤0.01% 2553

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Northern Trust's RVMD Position: Q2 2026 in Review

Northern Trust increased its Revolution Medicines (RVMD) stake by 17% in Q2 2026, buying an estimated $23.8M and bringing the position to 1,117,110 shares worth $209M. The position accounts for 0.02% of the portfolio, ranked #498.

Northern Trust first reported a position in RVMD in Q1 2020 and has held it in 26 quarters since. 691 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Northern Trust held 1,117,110 shares of Revolution Medicines worth $209M as of Q2 2026.
  • Northern Trust bought 162,854 Revolution Medicines shares in Q2 2026, an estimated $23.8M.
  • Revolution Medicines made up 0.02% of Northern Trust's portfolio in Q2 2026, its #498 holding.
  • Northern Trust first reported a position in Revolution Medicines in Q1 2020 and has held it in 26 quarters since.
  • 691 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.